Author Correction: Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours

Lasko, Loren M.; Jakob, Clarissa G.; Edalji, Rohinton P.; Qiu, Wei; Montgomery, Debra; Digiammarino, Enrico L.; Hansen, T. Matt; Risi, Roberto M.; Frey, Robin; Manaves, Vlasios; Shaw, Bailin; Algire, Mikkel; Hessler, Paul; Lam, Lloyd T.; Uziel, Tamar; Faivre, Emily; Ferguson, Debra; Buchanan, Fritz G.; Martin, Ruth L.; Torrent, Maricel; Chiang, Gary G.; Karukurichi, Kannan; Langston, J. William; Weinert, Brian T.; Choudhary, Chunaram; Vries, Peter; Kluge, Arthur F.; Patane, Michael A.; Drie, John H.; Wang, Ce; McElligott, David; Kesicki, Edward A.; Marmorstein, Ronen; Sun, Chaohong; Cole, Philip A.; Rosenberg, Saul H.; Michaelides, Michael R.; Lai, Albert; Bromberg, Kenneth D.

Author Correction: Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours

Loren M. Lasko, Clarissa G. Jakob, Rohinton P. Edalji, Wei Qiu, Debra Montgomery, Enrico L. Digiammarino, T. Matt Hansen, Roberto M. Risi, Robin Frey, Vlasios Manaves, Bailin Shaw, Mikkel Algire, Paul Hessler, Lloyd T. Lam, Tamar Uziel, Emily Faivre, Debra Ferguson, Fritz G. Buchanan, Ruth L. Martin, Maricel Torrent, Gary G. Chiang, Kannan Karukurichi, J. William Langston, Brian T. Weinert, Chunaram Choudhary, Peter Vries, Arthur F. Kluge, Michael A. Patane, John H. Drie, Ce Wang, David McElligott, Edward A. Kesicki, Ronen Marmorstein, Chaohong Sun, Philip A. Cole, Saul H. Rosenberg, Michael R. Michaelides, Albert Lai and Kenneth D. Bromberg ()
Additional contact information
Loren M. Lasko: Discovery, Global Pharmaceutical Research and Development
Clarissa G. Jakob: Discovery, Global Pharmaceutical Research and Development
Rohinton P. Edalji: Discovery, Global Pharmaceutical Research and Development
Wei Qiu: Discovery, Global Pharmaceutical Research and Development
Debra Montgomery: Discovery, Global Pharmaceutical Research and Development
Enrico L. Digiammarino: Discovery, Global Pharmaceutical Research and Development
T. Matt Hansen: Discovery, Global Pharmaceutical Research and Development
Roberto M. Risi: Discovery, Global Pharmaceutical Research and Development
Robin Frey: Discovery, Global Pharmaceutical Research and Development
Vlasios Manaves: Discovery, Global Pharmaceutical Research and Development
Bailin Shaw: Discovery, Global Pharmaceutical Research and Development
Mikkel Algire: Discovery, Global Pharmaceutical Research and Development
Paul Hessler: Discovery, Global Pharmaceutical Research and Development
Lloyd T. Lam: Discovery, Global Pharmaceutical Research and Development
Tamar Uziel: Discovery, Global Pharmaceutical Research and Development
Emily Faivre: Discovery, Global Pharmaceutical Research and Development
Debra Ferguson: Discovery, Global Pharmaceutical Research and Development
Fritz G. Buchanan: Discovery, Global Pharmaceutical Research and Development
Ruth L. Martin: Discovery, Global Pharmaceutical Research and Development
Maricel Torrent: Discovery, Global Pharmaceutical Research and Development
Gary G. Chiang: Discovery, Global Pharmaceutical Research and Development
Kannan Karukurichi: Petra Pharma Corporation
J. William Langston: Faraday Pharmaceuticals
Brian T. Weinert: University of Copenhagen
Chunaram Choudhary: University of Copenhagen
Peter Vries: Cascadian Therapeutics, Inc.
Arthur F. Kluge: I-to-D, Inc.
Michael A. Patane: Mitobridge, Inc.
John H. Drie: Van Drie Research
Ce Wang: China Novartis Institutes for BioMedical Research
David McElligott: Accelerator Corporation
Edward A. Kesicki: Petra Pharma Corporation
Ronen Marmorstein: University of Pennsylvania
Chaohong Sun: Discovery, Global Pharmaceutical Research and Development
Philip A. Cole: Johns Hopkins University
Saul H. Rosenberg: Discovery, Global Pharmaceutical Research and Development
Michael R. Michaelides: Discovery, Global Pharmaceutical Research and Development
Albert Lai: Discovery, Global Pharmaceutical Research and Development
Kenneth D. Bromberg: Discovery, Global Pharmaceutical Research and Development

Nature, 2018, vol. 558, issue 7710, E1-E1

Abstract: In the originally published version of this Letter, the authors Arthur F. Kluge, Michael A. Patane and Ce Wang were inadvertently omitted from the author list. Their affiliations are: I-to-D, Inc., PO Box 6177, Lincoln, Massachusetts 01773, USA (A.F.K.); Mitobridge, Inc. 1030 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA (M.A.P.); and China Novartis Institutes for BioMedical Research, No. 4218 Jinke Road, Zhangjiang Hi-Tech Park, Pudong District, Shanghai 201203, China (C.W.). These authors contributed to the interpretation of results and design of compounds. In addition, author ‘Edward A. Kesicki’ was misspelled as ‘Ed Kesicki’. These errors have been corrected online.

Date: 2018
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41586-018-0111-5 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:558:y:2018:i:7710:d:10.1038_s41586-018-0111-5

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/s41586-018-0111-5

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().